Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Watch: Google A.I. Can Detect Risk of Heart Disease Through Eye Scan

The search engine announced the news on Monday. Together with Verily, Google’s health-tech branch, they have developed an A.I. that can determine if a person has high blood pressure or is at risk of a stroke or heart attack, just by scanning their eye. Researchers were able to “train” the A.I. by showing it thousands…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want MarketScale to feature Healthcare?

Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.

Book a demo

The search engine announced the news on Monday. Together with Verily, Google’s health-tech branch, they have developed an A.I. that can determine if a person has high blood pressure or is at risk of a stroke or heart attack, just by scanning their eye. Researchers were able to “train” the A.I. by showing it thousands of images of scanned retinas, allowing it to recognize when a person is at risk for heart problems. Right now, the algorithm is about 70 percent accurate, meaning it still doesn’t perform as well as blood tests. If that percentage begins to creep up and rival the accuracy of blood tests, it could provide a cheaper diagnosis option.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic sign a 10-year alliance as ambient AI reshapes the EHR debate

Siemens Healthineers and Cleveland Clinic have entered into a 10-year alliance focusing on ambient AI and its integration into electronic health records (EHR). This partnership aims to enhance healthcare delivery systems and streamline clinical processes through advanced technology.

  • 01Siemens Healthineers and Cleveland Clinic have formed a 10-year partnership to explore ambient AI in healthcare.
  • 02The alliance focuses on transforming electronic health records (EHR) with the integration of new AI technologies.
  • 03The partnership aims to improve healthcare delivery and streamline clinical processes.

Aug 9, 2026

A Physician Entrepreneur's Journey in Specialty Care Expansion - Dr. Joe Pazona, CEO of VirtuCare

Dr. Joe Pazona shares insights into his journey as a physician entrepreneur focusing on specialty care expansion. He highlights the challenges and strategies involved in growing a healthcare business. The discussion offers valuable lessons for other healthcare professionals looking to innovate and expand in their practices.

  • 01A physician entrepreneur focuses on specialty care expansion.
  • 02Innovative strategies are necessary for growth in healthcare businesses.
  • 03Lessons from healthcare leaders can help others in the industry.

Aug 8, 2026

"Biotech in the Balance" - Dr. Jeremy Levin, author and Chair of Ovid Therapeutics

The article 'Biotech in the Balance' features insights from Dr. Jeremy Levin, the Chair of Ovid Therapeutics. It explores the current state and future prospects of the biotech industry in balancing innovation and regulation.

  • 01Dr. Jeremy Levin is the Chair of Ovid Therapeutics.
  • 02Balancing innovation and regulation is a key challenge in the biotech industry.

Aug 8, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512